In any case, there was no mortality signal associated with alteplase administered up to 24 hours after a stroke in HOPE.

DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, today announced the peer-reviewed publication entitled: ...

In research published in the December 2024 issue of Fluids and Barriers of the CNS ("Brain endothelial permeability, ...

Conclusions Immediate cerebral perfusion changes and the rate of stroke recurrences have no significant difference between the two groups. For patients who experience recurrent strokes/transient ...

med.uni-heidelberg.de Background We studied the effects of endovascular treatment (EVT) and the impact of the extent of recanalization on cerebral perfusion and oxygenation parameters in patients with ...

Compared to the anterior circulation, posterior circulation infarction (POCI ... and eight posterior cerebral artery occlusions. Voxel based ROC analysis of all patients in the group (Figure 1A) ...

Subarachnoid hemorrhage (SAH) is a devastating stroke subtype ... are currently no alternative approaches available. Cerebral autoregulation is a crucial homeostatic mechanism: its disruption in SAH ...

In our opinion previous ischaemic stroke ... no data to guide an acceptable timescale since the stroke. Selected intracranial space-occupying lesions, for example meningiomas, would not influence our ...